HiFiBiO: Personalized Drug Discovery at Lightspeed

HiFiBiO Therapeutics and CSEM are collaborating to develop and manufacture single-cell microfluidics that will enable novel immunotherapies for the treatment of cancer and autoimmune diseases. A new...